Introduction: Adhesive capsulitis (frozen shoulder) has an incidence of 3-5% in the general population. This disorder is one of the most common musculoskeletal problem seen in orthopaedics. Aims and objectives 1. The study was designed to assess the effectiveness of suprascapular nerve block (SSNB) and intra articular steroid (IAS) to relieve pain and improve range of motion. 2. To assess which one had better results in terms of simple pain score and SPADI (shoulder pain and disability index) score along with range of movement at shoulder joint. 3. To record any adverse effects and complications. In early follow ups there was significant improvement in abduction in IAS group than SSNB group, but at final follow up almost normal range of motion was achieved in both the groups. The average improvement in abduction in SSNB group was 86.92º and 68.46º in IAS group. Both groups achieved almost normal range of ER movement at final follow up. The average improvement in ER was ).All groups achieved significant improvement in pain and restriction of movement and achieved almost normal day to day activity at final follow up. Overall good to excellent results were seen in both the groups.
Introduction
Painful stiffness of the glenohumeral joint is popularly known as frozen shoulder, first described by Duplay in 1872. Frozen shoulder is characterised by shoulder pain of more than 4 weeks duration and accompanied by a reduction in glenohumeral movement of atleast 50% in all directions. Adhesive capsulitis (frozen shoulder) has an incidence of 3-5% in the general population and upto 20% in those with diabetes. This disorder is one of the most common musculoskeletal problem seen in orthopaedics. Historically frozen shoulder has been regarded as a condition from which "recovery is always sure and may be confidently expected". Several investigators using a variety of treatment methods have reported that a high percentage of affected patients obtain a full range of motion of the shoulder as well as complete or nearly complete relief of symptoms. However, other investigators questioned these optimistic findings and reported, measurable restriction at the time of follow up in 39-76% of patients and persistent symptoms in as many as 45%.
Materials and methods

Aims and objectives 2.1.1
The study was designed to assess the effectiveness of suprascapular nerve block and intra articular steroid to relieve pain and improve range of motion. 2.1.2 To assess which one had better results in terms of simple pain score and SPADI score along with range of movement at shoulder joint.
2.1.3
To record any adverse effects and complications.
Study center
The study was conducted in department of orthopaedics, S.M.S. Medical college and attached group of hospitals, Jaipur with due permission from institutional ethical committee and review board after taking informed and written consent from the patient from 1.4.2015 to 1.4.2016
Study design:
hospital based, prospective, randomized, comparative study.
Sample size:
sample size was calculated to be 23 subjects in each of 2 groups at alpha error of 0.05 and power 80% assuming detectable difference in mean of external rotation to be 30 degrees and S.D. 35 (as per seed articles), hence for study purpose 26 subjects were taken for each group including 10% attrition /dropout / loss of follow up in each group.
2.5
Randomisation: patients were randomised in 2 groups using chit in the box method.
2.6 Procedure 2.6.1 Group A: suprascapular nerve block group: 40 mg methyl prednisolone + 9.5 ml of bupivacaine hydrochloride given under supervision of anesthetist.
Group B:
intra articular steroid group: 40 mg methyl prednisolone acetate + 5ml 2% lidocaine hydrochloride given through posterior approach to shoulder. 
Clinical assessment
Clinical history: To elicit duration of symptoms, specific aggravating / relieving factors, any other significant medical / surgical illness specially diabetes mellitus, any other significant orthopaedic condition.
Assessment of pain
Simple pain score was recorded on 10 cm visual analogue scales for night pain, pain on movement and rest pain during the day. 
Treatment options Group A: suprascapular nerve block
The technique consists of injecting anesthetic in supraspinatus fossa of affected shoulder, with the patient sitting down and upper limbs pending beside the body. The health care provider must palpate anatomical parameters like clavicle, acromioclavicular articulation, acromion, scapula spine and coracoid process. This entire area is sterilized with alcohol, the needle introduction site is medial to vertex obtained from two imaginary lines traced over upper edge of clavicle and anterior edge of scapula spine, laterally to the coracoid process. It is in this location that Neviaser portal is made in the arthroscopic surgery of shoulder. The needle is advanced in craniocaudal direction, perpendicular to skin, crossing the trapezium and supraspinatus muscles, until it reaches the supraspinatus fossa (3 to 4 cm), adjacent to coracoid process basis where the nerve is located. Sometimes the patient reports a slight paresthesia on lateral surface of affected arm or shoulder. The needle must be aspired, before infusion of anesthetic solution so that there is no risk this solution enters the bloodstream directly.
Group B:
Intra articular steroid The needle should be inserted 2 to 3 cm inferior to the posterolateral corner of the acromion and directed anteriorly in the direction of the coracoid process. As with any injection, aspiration should be done to ensure that there has not been needle placement in the blood vessel. The injection should be performed slowly, but with consistent pressure. Follow-up care should include the following recommendations. Patients should remain seated or placed in supine position for several minutes after the injection. To ascertain whether the pharmaceuticals have been delivered to the appropriate location, the joint or area may be put through passive range of motion. The patient should remain in the office to be monitored for 30 minutes after the injection, and the patient should avoid strenuous activity involving the injected region for at least 48 hours. Patients should be cautioned that they might experience worsening symptoms during the first 24 to 48 hours, related to a possible steroid flare, which can be treated with ice and NSAIDs. A follow-up examination should be arranged within three weeks. 
Final outcome assessment
Was done with comparison of SPADI at first visit, 1 week, 3 weeks, 7 weeks and 12 weeks. 
Results and discussion
Conclusions
 All groups achieved significant improvement in pain and restriction of movement and achieved almost normal day to day activity at final follow up.  Overall good to excellent results were seen in both the groups.
It is important in developing countries like India to find a cost effective and safe procedure to reduce the morbidity of the condition. The procedures are simple and cost effective. In our impression, spontaneous recovery does not necessarily occur even after a long period, so we therefore recommend that these modalities should be offered to all patients with frozen shoulder and suggest that these modalities would be of more value if carried out at an early stage of the disorder.
